Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir in genotype 1 hepatitis C non-responders
NCT00781274Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Dec 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of telaprevir in hepatitis C (HCV), sponsored by Mitsubishi Tanabe Pharma. Primary endpoint: Sustained Viral Response. Started Dec 2008; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00781274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781274.